Akèy › Astrositòm
Etid klinik pou Astrositòm ap rekrite nan Etazini
45 etid pou Astrositòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX14 etid
- Boston, MA13 etid
- New York City, NY9 etid
- Chicago, IL9 etid
- Miami, FL7 etid
- Seattle, WA7 etid
- Philadelphia, PA7 etid
- Washington, DC6 etid
- Columbus, OH6 etid
- Durham, NC6 etid
- San Francisco, CA5 etid
- Cincinnati, OH5 etid
- Aurora, CO5 etid
- Baldwin Park, CA4 etid
- Salt Lake City, UT4 etid
- Birmingham, AL3 etid
- St. Louis, MO3 etid
- Dallas, TX3 etid
- Kansas City, KS3 etid
- Edison, NJ3 etid
- Detroit, MI3 etid
- Lexington, KY3 etid
- Nashville, TN3 etid
- Los Angeles, CA3 etid
- Rochester, MN3 etid
- Pittsburgh, PA3 etid
- New Haven, CT3 etid
- San Antonio, TX3 etid
- Queens, NY3 etid
- Ann Arbor, MI3 etid
Pa eta
- Alabama3 etid
- Colorado5 etid
- Connecticut3 etid
- Distrik Columbia4 etid
- Florid9 etid
- Illinois9 etid
- Kalifòni10 etid
- Kansas3 etid
- Kentucky4 etid
- Massachusetts13 etid
- Michigan6 etid
- Minnesota5 etid
- Missouri4 etid
- New Jersey3 etid
- New York9 etid
- North Carolina7 etid
- Ohio8 etid
- Pennsylvania8 etid
- Tennessee4 etid
- Texas15 etid
- Utah4 etid
- Virginia3 etid
- Washington8 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05765812VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Ap rekriteFaz 2
Laj 18 a 98 · Tout sèks · Mizajou Sep 21, 2026 · NCT07831369A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Ap rekriteFaz 1/2
Laj 2 a 24 · Tout sèks · Mizajou Sep 11, 2026 · NCT04923126FearLess in NeuroOncology
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06989086Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Serial MRI Scans During Radiation Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04188535Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06860594Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07215910Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Aug 14, 2026 · NCT06344130Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
Laj 18 a 130 · Tout sèks · Mizajou Aug 12, 2026 · NCT05417594Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07544992Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT07733674Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT04623931Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT06815029Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07468136A Study of 177Lu-PSMA-617 in People With Gliomas
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT07223034Loupe-Based Intraoperative Fluorescence Imaging
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Jun 3, 2026 · NCT04780009Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT01269853Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.